A California-based medical marijuana company’s effort to file an amicus brief in a medical marijuana lawsuit in New York should be rejected, the five medical marijuana companies that were recently awarded a license by the state argued in court documents.
The intervenors in the lawsuit, New York Medical Cannabis Industry Association v. New York State Department of Health, No. 2848-17—who were granted licenses to grow and sell medical marijuana in New York in August (NYLJ, Aug. 1)—filed a memorandum of law late last week in opposition to West Sacramento Management Group LLC’s motion for leave to file an amicus curiae brief in the lawsuit against the state by the original five medical marijuana companies.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
